Comparison of Sub-dissociative Dose Intranasal Ketamine to Intranasal Fentanyl for Treatment of Moderate to Severe Pain in Pediatric Patients Presenting to the Emergency Department: a Prospective, Randomized, Double-blind Study
Status: Terminated
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
Direct comparison of intranasal sub-dissociative dose ketamine with intranasal fentanyl for the treatment of moderate to severe pain in pediatric patients in the emergency department.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Maximum Age: 17
Healthy Volunteers: f
View:
• Children aged 3-17,
• weighing less than 50kg
• present to the pediatric ED with moderate-severe acute pain (defined as pain greater than or equal to 6/10).
• Treating physician determines the patient to require opioid analgesia.
Locations
United States
New York
Maimonides Medical Center
Brooklyn
Time Frame
Start Date: 2015-05-01
Completion Date: 2017-10-14
Participants
Target number of participants: 22
Treatments
Experimental: Ketamine
intranasal sub-dissociative dose ketamine for the treatment of moderate to severe pain in pediatric patients in the emergency department.
Active_comparator: Fentanyl
intranasal fentanyl for the treatment of moderate to severe pain in pediatric patients in the emergency department.
Authors
Sponsors
Leads: Antonios Likourezos
Collaborators: Maimonides Medical Center